Browse All

Current Filters

CLEAR FILTER x

TITLE

Equitable Implementation of Highly Efficacious Treatments for Multiple Sclerosis

Author:Langer-Gould, Annette   Li, Bonnie   Smith, Jessica   Kanter, Michael   Choi, Kristen   Xu, Stanley   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.001  

Author Institution:Southern California Permanente Medical Group, Los Angeles, CA  Southern California Permanente Medical Group, Pasadena, CA  

Multiple Sclerosis in the Emergency Department: A Retrospective Case-control Study in a Large U.S. Center

Author:Satish, Siddharth   Patel, Amrapali   Mastick, Maya   Lee, Seungwon   Hotan, Gladia   Ham, Andrew Siyoon   Chen, Tina   Tsai, Emily   Mateen, Farrah   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.002  

Author Institution:Harvard College, West Windsor, NJ  Massachusetts General Hospital, Richmond, TX  Harvard College, Cambridge, MA  Massachusetts General Hospital, Boston, MA  Institute of High Performance Computing, A*STAR, Singapore, Singapore  

Ocrelizumab Subcutaneous Administration: Further Characterization of the Benefit–Risk Profile from the OCARINA II Study and Patient Preferences

Author:Newsome, Scott   Goldstick, Lawrence   Selmaj, Krzysztof   Krzystanek, Ewa   Zecevic, Dusanka   Figueiredo, Catarina   Clinch, Susanne   Giacobino, Caroline   Azmi, Jay   Centonze, Diego   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.003  

Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD, USA, Baltimore, MD  Department of Neurology and Rehabilitation Waddell Center for Multiple Sclerosis, University of Cincinnati, College of Medicine, Cincinnati, OH, USA, Cincinnati, OH  Centrum Neurologii, Lódz, Poland, Lódz, Poland  Department of Neurology, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland, Katowice, Poland  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  Unit of Neurology, IRCCS Neuromed, Pozzilli (IS), Italy, Rome, Italy  

Neutropenia and Neutropenic Fever in Patients with Multiple Sclerosis on B-cell Depleting Therapies

Author:Doerfler, Matthew   Alvarez, Enrique   Wolf, Andrew   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.004  

Author Institution:University of Colorado, Aurora, CO  

Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension

Author:Oh, Jiwon   Drulovic, Jelena   Dufek, Michal   Budincevic, Hrvoje   Habek, Mario   Caunt, Maresa   Sierzega, Malgorzata   Clayton, David   Chen, Ying-Fang   Ratchford, Jack   Goodyear, Alexandra   Bar-Or, Amit   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.005  

Author Institution:St. Anne's University Hospital Brno, Teplice, Czech Republic  Solmed Polyclinic and Sveti Duh University Hospital, Zagreb, Croatia  University Hospital Center Zagreb, Zagreb, Croatia  Genentech, Inc., South San Francisco, CA  F. Hoffmann-La Roche Ltd, Basel, Switzerland  University of Pennsylvania, Philadelphia, PA